User profiles for K. Swanson

Kelly S Swanson

- Verified email at illinois.edu - Cited by 18217

Karen V Swanson

- Verified email at med.unc.edu - Cited by 5152

[HTML][HTML] Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of …

…, K Scott, C Stanton, KS Swanson… - Nature reviews …, 2017 - nature.com
In December 2016, a panel of experts in microbiology, nutrition and clinical research was
convened by the International Scientific Association for Probiotics and Prebiotics to review the …

A gene map of the human genome

…, M Sandusky, K Schmitt, R Berry, K Swanson… - Science, 1996 - science.org
The human genome is thought to harbor 50,000 to 100,000 genes, of which about half have
been sampled to date in the form of expressed sequence tags. An international consortium …

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

KV Swanson, M Deng, JPY Ting - Nature Reviews Immunology, 2019 - nature.com
… of K + efflux 38 . Another recent study separated the contribution of K + efflux from Cl − efflux
by inhibiting K + or … They showed that the role of K + efflux is to drive NLRP3 oligomerization, …

[HTML][HTML] Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

…, KA Swanson, S Roychoudhury, K Koury… - New England journal …, 2020 - Mass Medical Soc
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …

[HTML][HTML] Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months

…, C Zerbini, R Bailey, KA Swanson… - … England Journal of …, 2021 - Mass Medical Soc
Background BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine
encoding a prefusion-stabilized, membrane-anchored severe acute respiratory syndrome …

[HTML][HTML] COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

…, PY Shi, C Fontes-Garfias, JL Perez, KA Swanson… - Nature, 2020 - nature.com
An effective vaccine is needed to halt the spread of the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) pandemic. Recently, we reported safety, tolerability and …

[HTML][HTML] Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates

…, R Bailey, KA Swanson, P Li, K Koury… - … England Journal of …, 2020 - Mass Medical Soc
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections
and the resulting disease, coronavirus disease 2019 (Covid-19), have spread to millions of …

[HTML][HTML] Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age

…, KA Swanson, H Ma, X Xu, K Koury… - … England Journal of …, 2022 - Mass Medical Soc
Background Safe, effective vaccines against coronavirus disease 2019 (Covid-19) are urgently
needed in children younger than 12 years of age. Methods A phase 1, dose-finding study …

[HTML][HTML] Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants

…, KU Jansen, AS Anderson, KA Swanson… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether vaccination during pregnancy could reduce the burden of respiratory
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …

[HTML][HTML] Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents

…, KA Swanson, H Ma, X Xu, K Koury… - … England Journal of …, 2021 - Mass Medical Soc
Background Until very recently, vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) had not been authorized for emergency use in persons younger than …